Immunobiological activities of chemically defined lipid A from Helicobacter pylori LPS in comparison with Porphyromonas gingivalis lipid A and Escherichia coli-type synthetic lipid A (compound 506)

By Ogawa T.   Suda Y.   Kashihara W.   Hayashi T.   Shimoyama T.   Kusumoto S.   Tamura T.  

Vaccine, Vol. 15, Iss. 15, 1997-10 ,pp. : 1598-1605

Elsevier

Access to resources Recommend Favorite

Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis

By Ross B.C.   Czajkowski L.   Hocking D.   Margetts M.   Webb E.   Rothel L.   Patterson M.   Agius C.   Camuglia S.   Reynolds E.   Littlejohn T.   Gaeta B.   Ng A.   Kuczek E.S.   Mattick J.S.   Gearing D.   Barr I.G.  

Vaccine, Vol. 19, Iss. 30, 2001-07 ,pp. : 4135-4142

Elsevier

Access to resources Recommend Favorite

Enhanced immunogenicity of a recombinant genital warts vaccine adjuvanted with monophosphoryl lipid A

By Thompson H.S.G.   Davies M.L.   Watts M.J.   Mann A.E.   Holding F.P.   O'Neill T.   Beech J.T.   Thompson S.J.   Leesman G.D.   Ulrich J.T.  

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 1993-1999

Elsevier

Access to resources Recommend Favorite

Specific antibodies induced by nasally administered 40-kDa outer membrane protein of Porphyromonas gingivalis inhibits coaggregation activity of P. gingivalis

By Namikoshi J.   Otake S.   Maeba S.   Hayakawa M.   Abiko Y.   Yamamoto M.  

Vaccine, Vol. 22, Iss. 2, 2003-12 ,pp. : 250-256

Elsevier

Access to resources Recommend Favorite

Antagonistic effect of synthetic peptides corresponding to the binding regions within fimbrial subunit protein from Porphyromonas gingivalis to human gingival fibroblasts

By Ogawa T.   Ogo H.   Kinoshita A.  

Vaccine, Vol. 15, Iss. 2, 1997-02 ,pp. : 230-236

Elsevier

Access to resources Recommend Favorite